The DOI matches its Crossref record; 63 of the 73 references it cites were found in a registry or an index.
DNA Damage-Induced Phosphorylation of p53 Alleviates Inhibition by MDM2
Open accessAbstract
DNA-damaging agents signal to p53 through as yet unidentified posttranscriptional mechanisms. Here we show that phosphorylation of human p53 at serine 15 occurs after DNA damage and that this leads to reduced interaction of p53 with its negative regulator, the oncoprotein MDM2, in vivo and in vitro. Furthermore, using purified DNA-dependent protein kinase (DNA-PK), we demonstrate that phosphorylation of p53 at serines 15 and 37 impairs the ability of MDM2 to inhibit p53-dependent transactivation. We present evidence that these effects are most likely due to a conformational change induced upon phosphorylation of p53. Our studies provide a plausible mechanism by which the induction of p53 can be modulated by DNA-PK (or other protein kinases with similar specificity) in response to DNA damage.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Doxorubicin treatment of early passage tumor cell lines revealed that five of five early generation mTerc Ink4a / Arf -/ -tumors maintained intact p53 response evidenced by p53 Ser-18 phosphorylation (37, 38) and associated induction of p21 CIP1 .”
From Ink4a / Arf tumor suppressor does not modulate the degenerative conditions or tumor spectrum of the telomerase-deficient mouse (2007) · cites this paper as [37]
In the citing paper
“Induction of double strand breaks in DNA by ionizing radiation or genotoxic chemotherapy leads to the rapid stabilization of p53 through phosphorylation of its N terminus (Shieh et al. 1997; Siliciano et al. 1997”
From p53 Deficiency Rescues the Adverse Effects of Telomere Loss and Cooperates with Telomere Dysfunction to Accelerate Carcinogenesis (1999) · cites this paper as Shieh et al. 1997
In the citing paper
“ATM also activates Chk2, which in turn phosphorylates p53 on serine 20 and inhibits MDM2 binding (Shieh et al, 1997;Banin et al, 1998;Chehab et al, 2000;Shieh et al, 2000).”
From ATM and Chk2-dependent phosphorylation of MDMX contribute to p53 activation after DNA damage (2005) · cites this paper as Shieh et al, 1997
In the citing paper
“ATM also activates Chk2, which in turn phosphorylates p53 on S20, which is a part of the MDM2-binding site (Shieh et al, 1997(Shieh et al, , 2000;;Banin et al, 1998;Chehab et al, 2000).”
From ATM activates p53 by regulating MDM2 oligomerization and E3 processivity (2009) · cites this paper as Shieh et al, 1997
In the citing paper
“Several landmark studies showed that DNA double strand breaks induce phosphorylation of p53 S15 by DNA-PK and ATM (Mayo et al, 1997;Shieh et al, 1997;Banin et al, 1998;Prives and Hall, 1999).”
From ATM activates p53 by regulating MDM2 oligomerization and E3 processivity (2009) · cites this paper as Shieh et al, 1997
Citations
Cites
p53, the cellular gatekeeper for growth and division
Levine, A. J. (1997) · Cell · doi:10.1016/s0092-8674(00)81871-1 · Cited by 7,693
Mdm2 promotes the rapid degradation of p53
Haupt, Y., Maya, R., Kazaz, A., & Oren, M. (1997) · Nature · doi:10.1038/387296a0 · Cited by 4,506
Regulation of p53 stability by Mdm2
Kubbutat, M. H. G., Jones, S. N., & Vousden, K. H. (1997) · Nature · doi:10.1038/387299a0 · Cited by 3,312
Momand, J., Zambetti, G. P., Olson, D. C., George, D., & Levine, A. J. (1992) · Cell · doi:10.1016/0092-8674(92)90644-r · Cited by 3,113
Kastan, M. B., Zhan, Q., El-Deiry, W. S., Carrier, F., Jacks, T., Walsh, W. V., Plunkett, B. S., Vogelstein, B., & Fornace, A. J. (1992) · Cell · doi:10.1016/0092-8674(92)90593-2 · Cited by 3,047
A Single Ataxia Telangiectasia Gene with a Product Similar to PI-3 Kinase
Savitsky, K., Bar-Shira, A., Gilad, S., Rotman, G., Ziv, Y., Vanagaite, L., Tagle, D. A., Smith, S., Uziel, T., Sfez, S., et al. (1995) · Science · doi:10.1126/science.7792600 · Cited by 2,785
p53: puzzle and paradigm.Preprint
Ko, L. J., & Prives, C. L. (1996) · Genes & Development · doi:10.1101/gad.10.9.1054 · Cited by 2,346
Self-citationStructure of the MDM2 Oncoprotein Bound to the p53 Tumor Suppressor Transactivation Domain
Kussie, P. H., Gorina, S., Marechal, V., Elenbaas, B., Moreau, J., Levine, A. J., & Pavletich, N. P. (1996) · Science · doi:10.1126/science.274.5289.948 · Cited by 2,206
The p53-mdm-2 autoregulatory feedback loop.
Wu, X., Bayle, J. H., Olson, D., & Levine, A. J. (1993) · Genes & Development · doi:10.1101/gad.7.7a.1126 · Cited by 1,801
Oncoprotein MDM2 conceals the activation domain of tumour suppressor p53
Oliner, J. D., Pietenpol, J. A., Thiagalingam, S., Gyuris, J., Kinzler, K. W., & Vogelstein, B. (1993) · Nature · doi:10.1038/362857a0 · Cited by 1,474
Research works printed but not linked: 3
- Hawley, 1996, Stange bedfellows in even stranger places, Genes Dev., 10, 1383
- Meek, 1994, Posttranslational modification of p53, Semin. Cancer Biol., 5, 203
- Nelson, 1994, DNA strand breaks, Mol. Cell. Biol., 14, 1815
Cited by
Sorted by citations
Items 501–600 of 1,005
Meiotic Recombination Provokes Functional Activation of the p53 Regulatory Network
Lu, W.-J., Chapo, J. A., Roig, I., & Abrams, J. (2010) · Science · doi:10.1126/science.1185640 · Cited by 94
Resistance to docetaxel‐induced apoptosis in prostate cancer cells by p38/p53/p21 signaling
Gan, L., Wang, J., Xu, H., & Yang, X. (2011) · The Prostate · doi:10.1002/pros.21331 · Cited by 91
The PCAF acetylase complex as a potential tumor suppressor
Schiltz, R. L., & Nakatani, Y. (2000) · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer · doi:10.1016/s0304-419x(99)00037-2 · Cited by 90
Comparison of human COP9 signalosome and 26S proteasome ‘lid’
Henke, W., Ferrell, K., Bech‐Otschir, D., Seeger, M., Schade, R., Jungblut, P. R., Naumann, M., & Dubiel, W. (1999) · Molecular Biology Reports · doi:10.1023/a:1006991419464 · Cited by 90
Nuclear exclusion of p53 in a subset of tumors requires MDM2 function
Lu, W., Pochampally, R. R., Chen, L., Chomnawang, M. T., Wang, Y., & Chen, J. (2000) · Oncogene · doi:10.1038/sj.onc.1203262 · Cited by 90
Early Single Cell Bifurcation of Pro- and Antiapoptotic States during Oxidative Stress
Nair, V. D., Yuen, T., Olanow, C. W., & Sealfon, S. C. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m312135200 · Cited by 90
p51A (TAp63γ), a p53 homolog, accumulates in response to DNA damage for cell regulation
Katoh, I., Aisaki, K., Kurata, S., Ikawa, S., & Ikawa, Y. (2000) · Oncogene · doi:10.1038/sj.onc.1203644 · Cited by 90
Fornace, A. J., Amundson, S. A., Bittner, M. L., Myers, T. G., Meltzer, P. S., Weinsten, J. N., & Trent, J. M. (1999) · Europe PMC (PubMed Central) · Cited by 90
Regulation and activation of p53 and its family members
Lohrum, M. A. E., & Vousden, K. H. (1999) · Cell Death and Differentiation · doi:10.1038/sj.cdd.4400625 · Cited by 91
Wink, S., Hiemstra, S. W., Huppelschoten, S., Danen, E. H. J., Niemeijer, M., Hendriks, G., Vrieling, H., Herpers, B., & van de Water, B. (2014) · Chemical Research in Toxicology · doi:10.1021/tx4004038 · Cited by 93
Oncogenic Gain of Function in Glioblastoma Is Linked to Mutant p53 Amyloid Oligomers
Pedrote, M. M., Motta, M. F., Ferretti, G. D. S., Norberto, D. R., Spohr, T. C. L. S., Lima, F. R. S., Gratton, E., Silva, J. L., & de Oliveira, G. A. P. (2020) · iScience · doi:10.1016/j.isci.2020.100820 · Cited by 90
Wyttenbach, A., & Tolkovsky, A. M. (2006) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2005.03676.x · Cited by 90
Enk, C. D., Jacob–Hirsch, J., Gal, H., Verbovetski, I., Amariglio, N., Mevorach, D., Ingber, A., Givol, D., Rechavi, G., & Hochberg, M. (2006) · Oncogene · doi:10.1038/sj.onc.1209292 · Cited by 92
Ćmielová, J., Havelek, R., Soukup, T., Mrkvicová, A., Víšek, B., Suchánek, J., Vávrová, J., Mokrý, J., Muthná, D., Brůčková, L., et al. (2012) · International Journal of Radiation Biology · doi:10.3109/09553002.2012.666001 · Cited by 90
Mdm2 and Mdm4 Loss Regulates Distinct p53 Activities
Barboza, J., Iwakuma, T., Terzian, T., El‐Naggar, A. K., & Lozano, G. (2008) · Molecular Cancer Research · doi:10.1158/1541-7786.mcr-07-2079 · Cited by 91
Kelley, M. L., Winge, P., Heaney, J. D., Stephens, R. E., Farrell, J. H., Beneden, R. J. V., Reinisch, C. L., Lesser, M. P., & Walker, C. W. (2001) · Oncogene · doi:10.1038/sj.onc.1204144 · Cited by 89
Steelman, L. S., Navolanic, P. M., Chappell, W. H., Abrams, S. L., Wong, E. W. T., Martelli, A. M., Cocco, L., Stivala, F., Libra, M., Nicoletti, F., et al. (2011) · Cell Cycle · doi:10.4161/cc.10.17.17119 · Cited by 88
Gene-set analysis and reduction
Dinu, I. A., Potter, J. D., Mueller, T., Liu, Q., Adewale, A. J., Jhangri, G. S., Einecke, G., Famulski, K. S., Halloran, P. F., & Yasui, Y. (2008) · Briefings in Bioinformatics · doi:10.1093/bib/bbn042 · Cited by 91
Wang, W., Grégori, G., Hullinger, R. L., & ANDRISANI, O. M. (2004) · Molecular and Cellular Biology · doi:10.1128/mcb.24.23.10352-10365.2004 · Cited by 88
Lee, D., Rhee, J. G., & Lee, Y. J. (2009) · British Journal of Pharmacology · doi:10.1111/j.1476-5381.2009.00245.x · Cited by 89
Wu, F., Tian, F., Zeng, W., Liu, X., Fan, J., Lin, Y. C., & Zhang, Y. (2017) · Cell Death and Disease · doi:10.1038/cddis.2017.301 · Cited by 87
Stommel, J. M., & Wahl, G. M. (2005) · Cell Cycle · doi:10.4161/cc.4.3.1522 · Cited by 90
Tokumoto, M., Fujiwara, Y., Shimada, A., Hasegawa, T., Seko, Y., Nagase, H., & Satoh, M. (2011) · The Journal of Toxicological Sciences · doi:10.2131/jts.36.191 · Cited by 87
Strano, S., Rossi, M., Fontemaggi, G., Munarriz, E. R., Soddu, S., Sacchi, A., & Blandino, G. (2001) · FEBS Letters · doi:10.1016/s0014-5793(01)02119-6 · Cited by 87
Role of p53 in cell cycle regulation and apoptosis following exposure to proteasome inhibitors.
Chen, F., Chang, D., Goh, M., Klibanov, S. A., & Ljungman, M. E. (2000) · PubMed · Cited by 87
Accumulation of soluble and nucleolar-associated p53 proteins following cellular stress
Klibanov, S. A., O’Hagan, H. M., & Ljungman, M. E. (2001) · Journal of Cell Science · doi:10.1242/jcs.114.10.1867 · Cited by 88
Sun, H., Cai, H., Xu, C., Zhai, H., Lux, F., Xie, Y., Feng, L., Du, L., Liu, Y., Sun, X., et al. (2022) · Journal of Nanobiotechnology · doi:10.1186/s12951-022-01654-9 · Cited by 86
Mendoza, M. J., Mandani, G., & Momand, J. A. (2013) · BioMolecular Concepts · doi:10.1515/bmc-2013-0027 · Cited by 88
Transcriptomic profiling reveals p53 as a key regulator of doxorubicin-induced cardiotoxicity
McSweeney, K. M., Bozza, W. P., Alterovitz, W.-L., & Zhang, B. (2019) · Cell Death Discovery · doi:10.1038/s41420-019-0182-6 · Cited by 86
Huang, J., Yang, J., Maity, B., Mayuzumi, D., & Fisher, R. A. (2011) · Cancer Research · doi:10.1158/0008-5472.can-10-3397 · Cited by 86
Melatonin triggers p53Ser phosphorylation and prevents DNA damage accumulation
Santoro, R., Marani, M., Blandino, G., Muti, P. C., & Strano, S. (2011) · Oncogene · doi:10.1038/onc.2011.469 · Cited by 88
Kapoor, M., Hamm, R. L., Yan, W., Taya, Y., & Lozano, G. (2000) · Oncogene · doi:10.1038/sj.onc.1203300 · Cited by 86
Self-citationThe role of protein stability in the cell cycle and cancer
Elledge, S. J., & Harper, J. W. (1998) · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer · doi:10.1016/s0304-419x(98)00005-5 · Cited by 86
Tehrani, S. S., Karimian, A., Parsian, H., Majidinia, M., & Yousefi, B. (2017) · Journal of Cellular Biochemistry · doi:10.1002/jcb.26217 · Cited by 85
Inflammation and the chemical carcinogen benzo[a]pyrene: Partners in crime
Shi, Q., Godschalk, R., & van Schooten, F. (2017) · Mutation Research/Reviews in Mutation Research · doi:10.1016/j.mrrev.2017.08.003 · Cited by 88
Devhare, P. B., Meyer, K., Steele, R., Ray, R. B., & RAY, R. K. (2017) · Cell Death and Disease · doi:10.1038/cddis.2017.517 · Cited by 91
Targeting Biomolecular Condensation and Protein Aggregation against Cancer
Silva, J. L., Foguel, D., Ferreira, V. F., Vieira, T. C. R. G., Marques, M. A., Ferretti, G. D. S., Outeiro, T. F., Cordeiro, Y., & de Oliveira, G. A. P. (2023) · Chemical Reviews · doi:10.1021/acs.chemrev.3c00131 · Cited by 86
Curcumin and Vitamin E Protect against Adverse Effects of Benzo[a]pyrene in Lung Epithelial Cells
Zhu, W., Cromie, M. M., Cai, Q., Lv, T., Singh, K. P., & Gao, W. (2014) · PLoS ONE · doi:10.1371/journal.pone.0092992 · Cited by 85
Wang, L., Xiang, S., Williams, K. A., Dong, H., Bai, W., Nicosia, S. V., Khochbin, S., Bepler, G., & Zhang, X. M. (2012) · PLoS ONE · doi:10.1371/journal.pone.0044265 · Cited by 87
Solozobova, V. (2011) · World Journal of Biological Chemistry · doi:10.4331/wjbc.v2.i9.202 · Cited by 87
Functional Roles of the Human Cytomegalovirus Essential IE86 Protein
Stinski, M. F., & Petrik, D. T. (2008) · Current topics in microbiology and immunology · doi:10.1007/978-3-540-77349-8_8 · Cited by 85
Chen, P., Luo, X., Nie, P., Wu, B., Xu, W. G., Shi, X., Chang, H., Li, B., Yu, X., & Zou, Z. (2017) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2017.01.033 · Cited by 85
Regulation of Autophagy by Glucose in Mammalian Cells
Moruno, F., Pérez-Jiménez, E., & Knecht, E. (2012) · Cells · doi:10.3390/cells1030372 · Cited by 87
Ser392 Phosphorylation Regulates the Oncogenic Function of Mutant p53
Yap, D., Hsieh, J.-K., Zhong, S., Heath, V., Gusterson, B. A., Crook, T., & Lü, X. (2004) · Cancer Research · doi:10.1158/0008-5472.can-1305-2 · Cited by 84
Cyclin G1 associates with MDM2 and regulates accumulation and degradation of p53 protein
Kimura, S. H., & Nojima, H. (2002) · Genes to Cells · doi:10.1046/j.1365-2443.2002.00564.x · Cited by 85
Suppression of cell transformation and induction of apoptosis by caffeic acid phenethyl ester
Nomura, M., Kaji, A., Ma, W., Miyamoto, K., & Dong, Z. (2001) · Molecular Carcinogenesis · doi:10.1002/mc.1043 · Cited by 84
Homologous recombination as a mechanism for genome rearrangements: environmental and genetic effects
Bishop, A. J. R. (2000) · Human Molecular Genetics · doi:10.1093/hmg/9.16.2427 · Cited by 86
Targeting p53-MDM2-MDMX Loop for Cancer Therapy
Zhang, Q., Zeng, S. X., & Lu, H. (2014) · Sub-cellular biochemistry/Subcellular biochemistry · doi:10.1007/978-94-017-9211-0_16 · Cited by 85
BARD1 induces apoptosis by catalysing phosphorylation of p53 by DNA-damage response kinase
Féki, A., Jefford, C. E., Berardi, P., Wu, J., Cartier, L., Krause, K., & Irminger‐Finger, I. (2005) · Oncogene · doi:10.1038/sj.onc.1208491 · Cited by 85
Melchini, A., Costa, C., Τράκα, Μ., Miceli, N., Mithen, R. F., Pasquale, R. D., & Trovato, A. (2009) · Food and Chemical Toxicology · doi:10.1016/j.fct.2009.03.024 · Cited by 87
The role of SOG1, a plant-specific transcriptional regulator, in the DNA damage response
Yoshiyama, K., Kimura, S., Maki, H., Britt, A., & Umeda, M. (2014) · Plant Signaling & Behavior · doi:10.4161/psb.28889 · Cited by 86
Acridine derivatives activate p53 and induce tumor cell death through bax
Wang, W., Ho, W. C., Dicker, D. T., MacKinnon, C., Winkler, J. D., Marmorstein, R., & El‐Deiry, W. S. (2005) · Cancer Biology & Therapy · doi:10.4161/cbt.4.8.2134 · Cited by 83
Inclán, M., Albelda, M. T., Frias, J. C., Blasco, S., Verdejo, B., Serena, C., Salat-Canela, C., Diaz, M. L., García‐España, A., & García‐España, E. (2012) · Journal of the American Chemical Society · doi:10.1021/ja300538s · Cited by 83
Mechanism of p53-dependent Apoptosis Induced by 3-Methylcholanthrene
Kwon, Y.-W., Ueda, S., Ueno, M., Yodoi, J., & Masutani, H. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m105033200 · Cited by 83
Balance of Yin and Yang: Ubiquitylation-Mediated Regulation of p53 and c-Myc
Dai, M., Jin, Y., Gallegos, J. R., & Lu, H. (2006) · Neoplasia · doi:10.1593/neo.06334 · Cited by 85
Regulation of MDMX Expression by Mitogenic Signaling
Gilkes, D. M., Pan, Y., Coppola, D., Yeatman, T., Reuther, G. W., & Chen, J. (2008) · Molecular and Cellular Biology · doi:10.1128/mcb.01633-07 · Cited by 82
HDAC6 deacetylates p53 at lysines 381/382 and differentially coordinates p53-induced apoptosis
Ryu, H.-W., Shin, D.-H., Lee, D. H., Choi, J., Han, G., Lee, K. Y., & Kwon, S. H. (2017) · Cancer Letters · doi:10.1016/j.canlet.2017.01.033 · Cited by 82
Hagemeier, S. R., Barlow, E. A., Meng, Q., & Kenney, S. C. (2012) · Journal of Virology · doi:10.1128/jvi.01850-12 · Cited by 86
Deregulation and Targeting of TP53 Pathway in Multiple Myeloma
Jovanović, K., Escure, G., Demonchy, J., Willaume, A., de Wyngaert, Z. V., Farhat, M.-M., Chauvet, P., Facon, T. T. F., Quesnel, B., & Manier, S. (2019) · Frontiers in Oncology · doi:10.3389/fonc.2018.00665 · Cited by 86
Fraser, M. E., Chan, S., Chan, S. S. L., Fiscus, R. R., & Tsang, B. K. (2005) · Oncogene · doi:10.1038/sj.onc.1209251 · Cited by 82
G-protein-coupled Receptor Kinase 5 Phosphorylates p53 and Inhibits DNA Damage-induced Apoptosis
Chen, X., Zhu, H., Yuan, M., Fu, J., Zhou, Y., & Ma, L. (2010) · Journal of Biological Chemistry · doi:10.1074/jbc.m109.094243 · Cited by 84
Human glial chimeric mice reveal astrocytic dependence of JC virus infection
Kondo, Y., Windrem, M. S., Zou, L., Chandler-Militello, D., Schanz, S. J., Auvergne, R. M., Betstadt, S. J., Harrington, A. R., Johnson, M. D., Kazarov, A. R., et al. (2014) · Journal of Clinical Investigation · doi:10.1172/jci76629 · Cited by 84
Fitzgerald, A. L., Osman, A. A., Xie, T.-X., Patel, A. A., Skinner, H., Sandulache, V. C., & Myers, J. N. (2015) · Cell Death and Disease · doi:10.1038/cddis.2015.44 · Cited by 84
Importance of DNA damage checkpoints in the pathogenesis of human cancers
Poehlmann, A., & Roessner, A. (2010) · Pathology - Research and Practice · doi:10.1016/j.prp.2010.06.006 · Cited by 88
FBXW7 Confers Radiation Survival by Targeting p53 for Degradation
Cui, D., Xiong, X., Shu, J., Dai, X.-Q., Sun, Y., & Zhao, Y. (2019) · Cell Reports · doi:10.1016/j.celrep.2019.12.032 · Cited by 82
Banu, S. K., Stanley, J. A., Lee, J., Stephen, S. D., Arosh, J. A., Hoyer, P. B., & Burghardt, R. C. (2011) · Toxicology and Applied Pharmacology · doi:10.1016/j.taap.2011.01.011 · Cited by 83
HCMV IE2‐mediated inhibition of HAT activity downregulates p53 function
Hsu, C.-H., Chang, M. D., Tai, K., Yang, Y.-T., Wang, P.-S., Chen, C., Wang, Y., Lee, S.-C., Wu, C., & Juan, L. (2004) · The EMBO Journal · doi:10.1038/sj.emboj.7600239 · Cited by 81
The Circadian Clock Controls Sunburn Apoptosis and Erythema in Mouse Skin
Gaddameedhi, S., Selby, C. P., Kemp, M. G., Ye, R., & Sancar, A. (2014) · Journal of Investigative Dermatology · doi:10.1038/jid.2014.508 · Cited by 81
Antagonistic pleiotropy and p53
Ungewitter, E. K., & Scrable, H. J. (2008) · Mechanisms of Ageing and Development · doi:10.1016/j.mad.2008.06.002 · Cited by 88
Activation of p53 signaling initiates apoptotic death in a cellular model of Parkinson’s disease
Nair, V. D. (2006) · APOPTOSIS · doi:10.1007/s10495-006-6316-3 · Cited by 83
Kaur, M., Agarwal, R., & Agarwal, C. (2006) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.mct-06-0014 · Cited by 80
Gou, Y., Wang, J., Chen, S., Zhang, Z., Zhang, Y., Zhang, W., & Yang, F. (2016) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2016.07.041 · Cited by 80
Cellular responses to DNA damage
Wang, J. Y. (1998) · Current Opinion in Cell Biology · doi:10.1016/s0955-0674(98)80146-4 · Cited by 80
Wang, Y. V., Leblanc, M., Wade, M., Jochemsen, A. G., & Wahl, G. M. (2009) · Cancer Cell · doi:10.1016/j.ccr.2009.05.008 · Cited by 79
Genetic and Expression Profiles of Cerebellar Liponeurocytomas
Horstmann, S., Perry, A., Reifenberger, G., Giangaspero, F., Huang, H., Hara, A., Masuoka, J., Rainov, N. G., Bergmann, M., Heppner, F. L., et al. (2004) · Brain Pathology · doi:10.1111/j.1750-3639.2004.tb00065.x · Cited by 79
Brew, C. T., Aronchik, I., Hsu, J. C., Sheen, J.-H., Dickson, R. B., Bjeldanes, L. F., & Firestone, G. L. (2005) · International Journal of Cancer · doi:10.1002/ijc.21445 · Cited by 79
Nitric oxide induces phosphorylation of p53 and impairs nuclear export
Schneiderhan‐Marra, N., Budde, A., Zhang, Y., & Brüne, B. (2003) · Oncogene · doi:10.1038/sj.onc.1206431 · Cited by 80
Balakrishnan, K., Nimmanapalli, R., Ravandi, F., Keating, M. J., & Gandhi, V. V. (2006) · Blood · doi:10.1182/blood-2006-03-007468 · Cited by 79
p53-Dependent Induction of p21Cip1/WAF1/Sdi1 Protects against Oxygen-Induced Toxicity
Helt, C. E. (2001) · Toxicological Sciences · doi:10.1093/toxsci/63.2.214 · Cited by 79
Pizzi, S., Sertic, S., Orcesi, S., Cereda, C., Bianchi, M., Jackson, A. P., Lazzaro, F., Plevani, P., & Muzi-Falconi, M. (2014) · Human Molecular Genetics · doi:10.1093/hmg/ddu485 · Cited by 85
The Role of Caspase-2 in Regulating Cell Fate
Vigneswara, V., & Ahmed, Z. (2020) · Cells · doi:10.3390/cells9051259 · Cited by 87
Orba, Y., Suzuki, T., Makino, Y., Kubota, K., Tanaka, S., Kimura, T., & Sawa, H. (2009) · Journal of Biological Chemistry · doi:10.1074/jbc.m109.064311 · Cited by 81
DNA Damage Induces p53-dependent BRCA1 Nuclear Export
Feng, Z., Kachnic, L. A., Zhang, J., Powell, S. N., & Xia, F. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m404137200 · Cited by 85
Activation of DNA damage response pathways as a consequence of anthracycline-DNA adduct formation
Forrest, R. A., Swift, L. P., Rephaeli, A., Nudelman, A., Kimura, K., Phillips, D. R., & Cutts, S. M. (2012) · Biochemical Pharmacology · doi:10.1016/j.bcp.2012.02.026 · Cited by 82
Granata, C., Oliveira, R. S. F., Little, J. P., Renner, K., & Bishop, D. J. (2017) · Scientific Reports · doi:10.1038/srep44227 · Cited by 81
Stabilization and activation of p53 are regulated independently by different phosphorylation events
Chernov, M. V., Ramana, C. V., Adler, V., & Stark, G. R. (1998) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.95.5.2284 · Cited by 78
Tripathi, R. P., Samadder, T., Gupta, S., Surolia, A., & Shaha, C. (2011) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.mct-10-0606 · Cited by 79
Recent Developments in Texaphyrin Chemistry and Drug Discovery
Preihs, C., Arambula, J. F., Magda, D. J., Jeong, H., Yoo, D., Cheon, J., Siddik, Z. H., & Sessler, J. L. (2013) · Inorganic Chemistry · doi:10.1021/ic400226g · Cited by 77
Nerve growth factor receptor negates the tumor suppressor p53 as a feedback regulator
Zhou, X. Y., Hao, Q., Liao, P., Luo, S., Zhang, M., Hu, G., Liu, H., Zhang, Y.-W., Cao, B., Baddoo, M., et al. (2016) · eLife · doi:10.7554/elife.15099 · Cited by 84
Taylor, C. A., Sun, Z., Cliché, D. O., Hong, M., Eshaque, B., Jin, S., Hopkins, M. T., Thai, B., & Thompson, J. E. (2006) · Experimental Cell Research · doi:10.1016/j.yexcr.2006.09.030 · Cited by 77
Myc and E2F1 induce p53 through p14ARF-independent mechanisms in human fibroblasts
Lindström, M. S., & Wiman, K. G. (2003) · Oncogene · doi:10.1038/sj.onc.1206659 · Cited by 77
Decreased p21 levels are required for efficient restart of DNA synthesis after S phase block
Gottifredi, V., McKinney, K., Poyurovsky, M. V., & Prives, C. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m310373200 · Cited by 76
Self-citationControl of SUMO and Ubiquitin by ROS: Signaling and disease implications
Stankovic‐Valentin, N., & Melchior, F. (2018) · Molecular Aspects of Medicine · doi:10.1016/j.mam.2018.07.002 · Cited by 79
Enhanced antitumor activity of cerulenin combined with oxaliplatin in human colon cancer cells
Shiragami, R., Murata, S., Kosugi, C., Tezuka, T., Yamazaki, M., Hirano, A., Yoshimura, Y., Suzuki, M., Shuto, K., & Koda, K. (2013) · International Journal of Oncology · doi:10.3892/ijo.2013.1978 · Cited by 76
Lee, S., Kim, D., Choi, B., Ha, H., & Kim, K. (2005) · Journal of Biological Chemistry · doi:10.1074/jbc.m509509200 · Cited by 77
Oscillations of the p53-Akt Network: Implications on Cell Survival and Death
Wee, K. B., Surana, U., & Aguda, B. D. (2009) · PLoS ONE · doi:10.1371/journal.pone.0004407 · Cited by 77
DNA damage response to the Mdm2 inhibitor Nutlin-3
Verma, R., Rigatti, M. J., Belinsky, G. S., Godman, C. A., & Giardina, C. A. (2009) · Biochemical Pharmacology · doi:10.1016/j.bcp.2009.09.020 · Cited by 77
Sobral, L. M., Sousa, L. O., Coletta, R. D., Cabral, H., Greene, L. J., Tajara, E. H., Gutkind, J. S., Curti, C., & Leopoldino, A. M. (2014) · Molecular Cancer · doi:10.1186/1476-4598-13-32 · Cited by 76
What have animal models taught us about the p53 pathway?
Lozano, G., & Zambetti, G. P. (2005) · The Journal of Pathology · doi:10.1002/path.1704 · Cited by 78
Yu, B., Li, X., Zheng, W., Feng, Y., Wong, Y.-S., & Chen, T. (2014) · Journal of Materials Chemistry B · doi:10.1039/c4tb00399c · Cited by 75
Metadata
- Authors
- Shieh, S.-Y., Ikeda, M., Taya, Y., & Prives, C.
- Affiliations
- Columbia University (US)
- Medical & Biological Laboratories (Japan) (JP)
- National Cancer Center Research Institute (JP)
- Corresponding author
- Prives, Carol
- Venue
- Cell
- Publisher
- Elsevier BV
- Published
- 1997-10
- Volume
- 91
- Issue
- 3
- Pages
- 325-334
- ISSN
- 0092-8674 (ISSN-L)
- OpenAlex
- W1978518304
- Cited by
- 2,100
- References
- 73
- Citations by year
- 2026: 15 · 2025: 25 · 2024: 40 · 2023: 53 · 2022: 72 · 2021: 53 · 2020: 49 · 2019: 45 · 2018: 47 · 2017: 72 · 2016: 50 · 2015: 55 · 2014: 74 · 2013: 86 · 2012: 84
- FWCI
- 45.42
- Type
- journal article
- Language
- en
- Open access
- hybrid
- doi.org
- Licence
- Locations
- Cell (publishedVersion, cc-by-nc-nd)
- PubMed (publishedVersion)
- Funders
- National Cancer Institute (CA 58316)
- Topics
- Health Sciences › Medicine › Oncology › Cancer-related Molecular Pathways
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › DNA Repair Mechanisms
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Heat shock proteins research
- Keywords
- p53, MDM2, DNA damage response, DNA-dependent protein kinase, p53-MDM2 interaction, protein conformational change
- MeSH terms
- Binding Sites, DNA Damage, DNA-Binding Proteins, Humans, Nuclear Proteins, Phosphorylation, Proto-Oncogene Proteins, Serine, Tumor Cells, Cultured, Transcriptional Activation, Down-Regulation, Tumor Suppressor Protein p53, Protein Serine-Threonine Kinases, Protein Structure, Tertiary, Proto-Oncogene Proteins c-mdm2, DNA-Activated Protein Kinase
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
